Alant Health

MedTech Strategy · Commercialization · Innovation

A data-driven advisory firm led by Dr. Abed Hammoud.

Alant Health partners with medical-technology companies on strategy, commercialization, and innovation — 30+ years of technical, clinical, and commercial experience across surgical navigation, medical imaging, neurosurgical robotics, neuromodulation, and epilepsy surgery.

Deep Brain Stimulation (DBS) Society
IEEE Senior Member

30+ Years in MedTech

4 Successful exits

2 Public-company acquisitions

5 Specialty domains

Experience across leading MedTech organizations

Medtronic Renishaw WVU Rockefeller Neuroscience Institute

Current Roles

2026-current: Adjunct faculty (Instructor), Neuroradiology, at the West Virginia University School of Medicine — part of the WVU Rockefeller Neuroscience Institute. Building on Alant Health's strategic collaboration with RNI, focused on research and development in neuroimaging and neuromodulation.
2024-current: Founding member & Chief Technology Officer at Clee Medical SA. Developing innovative imaging and sensing technology to provide unparalleled access, vision, and navigation within the brain. Clee is a spin-off of the WYSS Center for Bio and Neuro Engineering.
2023-current: Chief Commercial Advisor at NxNeuro SA. Unveiling the future of diagnosis and surgical treatment of drug-resistant epilepsy.

Professional Experience

Pioneering Early-Stage Development

Engaged over the past 30+ years in various leading roles in successful startup companies:

Surgical Navigation Technologies Inc. - StealthStation™ image-guided surgical navigation platform. Founding member & senior engineer, the company was acquired in 1996 by Sofamor-Danek/Medtronic (NYSE:MDT, S&P100).
IntellX LLC - cloud-based patient-specific brain segmentation & mapping technology. Founding member & senior engineer, the company was acquired in 1999 by Medtronic.

Technology Roll-outs for Major Multinationals

Medtronic ACTIVA™ deep brain stimulation (DBS) neuro-modulation therapy. Clinical solutions & business development.
DIXI Medical SAS - Senior vice president of sales & marketing (Directeur Commercial), leading the global commercial organization of a leading company in neurosurgical implantable devices for epilepsy surgery.

Corporate Turnarounds

Schaerer Swiss surgical tables (founded in 1892) - Interim managing director, managed the company's acquisition by a private equity group in 2007.
Renishaw Mayfield SA - NeuroMate® neurosurgical robot. Founding member & CEO led the company's acquisition by Renishaw (LSE:RSW, FTSE 250) in 2008 and stayed as CEO until 2018.

Board Experience

2024-current: Board member at Clee Medical, Switzerland. Clee Medical develops advanced intraoperative imaging solutions, including high-resolution, real-time 3D Optical Coherence Tomography (OCT) technology, to enhance precision and safety in neurosurgery.
2023-current: Chair of the board at Cascador Health, Belgium. Cascador Health creates an entire ecosystem of providers and users of data, allowing them to share their knowledge and improve healthcare.
2017-2020: Board member at G-Ray, Switzerland. G-Ray specialized in advanced x-ray imaging technologies for medical imaging, aerospace, and security applications before ceasing operations.
2011-2017: Board member at Renishaw, Ireland. Renishaw is a global, high-precision metrology and healthcare technology group and a world leader in additive manufacturing.